Skip to main content

Insulin NPH


07-09-2018 | Insulin | News

Few efficacy and safety differences between long-acting insulins

The results of a network meta-analysis suggest that long-acting insulin analogs have broadly equivalent efficacy and safety in patients with type 2 diabetes, although some might be a little better for preventing nocturnal hypoglycemia.

Read more

Related topics


Journal articles and book chapters

08-23-2017 | Obesity | Review | Article

Weight management in patients with type 1 diabetes and obesity

Mottalib A et al. Curr Diab Rep 2017; 17: 92. doi: 10.1007/s11892-017-0918-8

08-18-2017 | Insulin | Review | Article

New basal insulins: A clinical perspective of their use in the treatment of type 2 diabetes and novel treatment options beyond basal insulin

Frias PF, Frias JP. Curr Diab Rep 2017; 17: 91. doi: 10.1007/s11892-017-0926-8